Skip to main content
OSTI.GOVU.S. Department of Energy Office of Scientific and Technical Information
U.S. Department of Energy
Office of Scientific and Technical Information
 

Investigation of a tellurium-packed column for isolation of astatine-211 from irradiated bismuth targets and demonstration of a semi-automated system

Journal Article · · Scientific Reports
 [1];  [2];  [2];  [2];  [2];  [2];  [2]
  1. Univ. of Washington, Seattle, WA (United States); DOE/OSTI
  2. Univ. of Washington, Seattle, WA (United States)
+ Show Author Affiliations

Astatine-211 is an attractive radionuclide for use in targeted alpha therapy of blood-borne diseases and micrometastatic diseases. Efficient isolation methods that can be adapted to robust automated 211At isolation systems are of high interest for improving the availability of 211At. Based on the early studies of Bochvarova and co-workers involving isolation of 211At from irradiated thorium targets, we developed a method for 211At isolation from bismuth targets using tellurium-packed columns. Dissolution of irradiated bismuth targets is accomplished using HNO3; however, 211At is not captured on the Te column material in this matrix. Our method involves slow addition of aqueous NH2OH·HCl to the Bi target dissolved in HNO3 to convert to a HCl matrix. The amount of NH2OH·HCl was optimized because (1) the quantity of NH2OH·HCl used appears to affect the radiolabeling yield of phenethyl-closo-decaborate(2-) (B10)-conjugated antibodies and (2) reducing the volume of NH2OH·HCl solution can effectively shorten the overall isolation time. A proof-of-concept semi-automated process has been demonstrated using targets containing ~0.96 GBq (~26 mCi) of 211At. High isolation yields (88–95%) were obtained. Radiochemical purity of the isolated 211At was assessed by radio-HPLC. Concentrations of Bi and Te contaminants in the 211At and the astatinated antibodies were evaluated using ICP-MS.

Research Organization:
Univ. of Washington, Seattle, WA (United States)
Sponsoring Organization:
USDOE Office of Science (SC), Nuclear Physics (NP)
Grant/Contract Number:
SC0013618; SC0018013
OSTI ID:
1624508
Journal Information:
Scientific Reports, Journal Name: Scientific Reports Journal Issue: 1 Vol. 9; ISSN 2045-2322
Publisher:
Nature Publishing GroupCopyright Statement
Country of Publication:
United States
Language:
English

References (28)

Design and evaluation of an external high-current target for production of 211 At journal October 2012
Wet harvesting of no-carrier-added 211At from an irradiated 209Bi target for radiopharmaceutical applications journal January 2004
Wet-chemistry method for the separation of no-carrier-added 211At/211gPo from 209Bi target irradiated by alpha-beam in cyclotron journal May 2008
Astatine-211 labeling: a study towards automatic production of astatinated antibodies journal September 2014
Solvent distribution studies of the chemistry of astatine journal January 1957
An automated flow system incorporating in-line acid dissolution of bismuth metal from a cyclotron irradiated target assembly for use in the isolation of astatine-211 journal April 2017
Targeted α-particle radiotherapy with 211At-labeled monoclonal antibodies journal October 2007
Development of a preclinical 211 Rn/ 211 At generator system for targeted alpha therapy research with 211 At journal May 2017
Separation of astatine-211 from bismuth metal journal January 1973
Dry-distillation of astatine-211 from irradiated bismuth targets: a time-saving procedure with high recovery yields journal August 2001
Preparation of 211At-Labeled Humanized Anti-Tac Using 211At Produced in Disposable Internal and External Bismuth Targets journal February 1998
Molecular Pathways: Targeted  -Particle Radiation Therapy journal December 2012
Durable donor engraftment after radioimmunotherapy using α-emitter astatine-211–labeled anti-CD45 antibody for conditioning in allogeneic hematopoietic cell transplantation journal February 2012
Astatine-211 conjugated to an anti-CD20 monoclonal antibody eradicates disseminated B-cell lymphoma in a mouse model journal March 2015
cGMP production of astatine-211-labeled anti-CD45 antibodies for use in allogeneic hematopoietic cell transplantation for treatment of advanced hematopoietic malignancies journal October 2018
Evaluation of a Wet Chemistry Method for Isolation of Cyclotron Produced [211At]Astatine journal September 2013
Wet harvesting of no-carrier-added 211At from an irradiated 209Bi target for radiopharmaceutical applications journal January 2005
Extraction of 211At from nitric acid solutions into various organic solvents for use as an α-source for radiation chemistry studies journal July 2017
Preparation and evaluation of para-[211At]astatobenzoyl labeled anti-renal cell carcinoma antibody A6H F(ab′)2. In vivo distribution comparison with para-[125I]iodobenzoyl labeled A6H F(ab′)2 journal November 1993
Separation of astatine-211 from bismuth metal journal January 1973
Dry-distillation of astatine-211 from irradiated bismuth targets: a time-saving procedure with high recovery yields journal August 2001
A cryotrap as flow reactor for synthesis of 211At labelled compounds journal March 1999
Preparation of 211At-Labeled Humanized Anti-Tac Using 211At Produced in Disposable Internal and External Bismuth Targets journal February 1998
Astatine-211 labeling of an antimelanoma antibody and its Fab fragment using N-succinimidyl p-[211At]astatobenzoate: comparisons in vivo with the p-[125I]iodobenzoyl conjugate journal May 1991
Reagents for Astatination of Biomolecules. 2. Conjugation of Anionic Boron Cage Pendant Groups to a Protein Provides a Method for Direct Labeling that is Stable to in Vivo Deastatination journal July 2007
Oxidation of hydroxylamine by nitrous and nitric acids journal June 1982
Kinetics, mechanism, and stoicheiometry of the oxidation of hydroxylamine by nitric acid journal January 1979
Molecular Pathways: Targeted  -Particle Radiation Therapy journal December 2012

Cited By (1)

Guest Edited Collection: Radioisotopes and radiochemistry in health science journal January 2020

Figures / Tables (7)

Figure 1(p. 2)figure Figure 1
Table 1(p. 2)table Table 1
Figure 2(p. 3)figure Figure 2
Table 2(p. 3)table Table 2
Figure 3(p. 4)figure Figure 3
Table 3(p. 4)table Table 3
Table 4(p. 4)table Table 4

Similar Records

A Solid-State Support for Separating Astatine-211 from Bismuth
Journal Article · Fri Apr 17 00:00:00 EDT 2020 · Inorganic Chemistry · OSTI ID:1688758
Evaluation of Novel Wet Chemistry Separation and Purification Methods to Facilitate Automation of Astatine-­211 Isolation
Technical Report · Tue Jul 19 00:00:00 EDT 2016 · OSTI ID:1335515

Related Subjects

38 RADIATION CHEMISTRY, RADIOCHEMISTRY, AND NUCLEAR CHEMISTRY
59 BASIC BIOLOGICAL SCIENCES
60 APPLIED LIFE SCIENCES
Molecular medicine
Nuclear chemistry
Science & Technology - Other Topics